Literature DB >> 20812872

Control of redox state and redox signaling by neural antioxidant systems.

Jan Lewerenz1, Pamela Maher.   

Abstract

The glutathione/glutathione disulfide (GSH/GSSG) redox pair forms the major redox couple in cells and as such plays a critical role in regulating redox-dependent cellular functions. Not only does GSH act as an antioxidant but it can also modulate the activity of a variety of different proteins. An impairment in GSH status is thought to be the precipitating event in a wide range of neurological disorders. Therefore, understanding how to maintain GSH in the CNS could provide a valuable therapeutic approach. Intracellular GSH levels are regulated by a complex series of pathways that include substrate transport and availability, rates of synthesis and regeneration, GSH utilization, and GSH efflux. To date, the most effective approaches for maintaining GSH levels in the CNS include enhancing cyst(e)ine uptake both directly and indirectly via transcriptional upregulation of system x(c)(-), increasing GSH synthesis via transcriptional upregulation of the rate limiting enzyme in GSH biosynthesis, and decreasing GSH utilization. Among the transcription factors that play critical roles in GSH metabolism are NF-E2-related factor 2 (Nrf2) and activating transcription factor 4 (ATF4). Thus, compounds that can upregulate these transcription factors may be particularly useful in promoting the functional maintenance of the CNS through their effects on GSH metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20812872     DOI: 10.1089/ars.2010.3600

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  17 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

2.  Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease.

Authors:  David Schubert; Devin Kepchia; Zhibin Liang; Richard Dargusch; Joshua Goldberg; Pamela Maher
Journal:  Mol Neurobiol       Date:  2019-05-19       Impact factor: 5.590

3.  Chemical modification of the multitarget neuroprotective compound fisetin.

Authors:  Chandramouli Chiruta; David Schubert; Richard Dargusch; Pamela Maher
Journal:  J Med Chem       Date:  2011-12-20       Impact factor: 7.446

4.  Activating transcription factor 4 modulates BDNF release from microglial cells.

Authors:  Pengling Sun; Xiangnan Li; Chengwen Chen; Qianbo Chen; Qing Ouyang; Fangting Liu; Zhenghua Xiang; Hongbin Yuan
Journal:  J Mol Neurosci       Date:  2013-09-27       Impact factor: 3.444

5.  An enhanced integrated stress response ameliorates mutant SOD1-induced ALS.

Authors:  Lijun Wang; Brian Popko; Raymond P Roos
Journal:  Hum Mol Genet       Date:  2013-12-23       Impact factor: 6.150

Review 6.  How fisetin reduces the impact of age and disease on CNS function.

Authors:  Pamela Maher
Journal:  Front Biosci (Schol Ed)       Date:  2015-06-01

7.  Acute hypoglycemia induces retinal cell death in mouse.

Authors:  Martine Emery; Daniel F Schorderet; Raphaël Roduit
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

8.  Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway.

Authors:  Houman Ashrafian; Gabor Czibik; Mohamed Bellahcene; Dunja Aksentijević; Anthony C Smith; Sarah J Mitchell; Michael S Dodd; Jennifer Kirwan; Jonathan J Byrne; Christian Ludwig; Henrik Isackson; Arash Yavari; Nicolaj B Støttrup; Hussain Contractor; Thomas J Cahill; Natasha Sahgal; Daniel R Ball; Rune I D Birkler; Iain Hargreaves; Daniel A Tennant; John Land; Craig A Lygate; Mogens Johannsen; Rajesh K Kharbanda; Stefan Neubauer; Charles Redwood; Rafael de Cabo; Ismayil Ahmet; Mark Talan; Ulrich L Günther; Alan J Robinson; Mark R Viant; Patrick J Pollard; Damian J Tyler; Hugh Watkins
Journal:  Cell Metab       Date:  2012-03-07       Impact factor: 27.287

9.  Protein carbonylation and aggregation precede neuronal apoptosis induced by partial glutathione depletion.

Authors:  Anushka Dasgupta; Jianzheng Zheng; Oscar A Bizzozero
Journal:  ASN Neuro       Date:  2012-04-10       Impact factor: 4.146

10.  Neuroprotective effects of erucin against 6-hydroxydopamine-induced oxidative damage in a dopaminergic-like neuroblastoma cell line.

Authors:  Andrea Tarozzi; Fabiana Morroni; Cecilia Bolondi; Giulia Sita; Patrizia Hrelia; Alice Djemil; Giorgio Cantelli-Forti
Journal:  Int J Mol Sci       Date:  2012-08-30       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.